Imaging strategies for follow-up during adjuvant nivolumab in esophageal cancer: A multicenter retrospective cohort study
Tamara J Huizer, Anniek Strijdhorst, Laurens V Beerepoot, Mark I van Berge Henegouwen, Leni van Doorn, Sarah Derks, Bas P L Wijnhoven, Bianca Mostert · 2026
Read Imaging strategies for follow-up during adjuvant nivolumab in esophageal cancer: A multicenter retrospective cohort study by Tamara J Huizer, Anniek Strijdhorst, Laurens V Beerepoot, Mark I van Berge Henegouwen, Leni van Doorn, Sarah Derks, Bas P L Wijnhoven, Bianca Mostert (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0350105.txt.
Description
Tamara J Huizer and co-authors reviewed follow-up scanning for oesophageal cancer patients on nivolumab after surgery in 2026. The drug lowers relapse risk after chemotherapy, radiation, and surgery, yet relapse stays common and the best scan schedule was unknown.
Records from three Dutch hospitals covered one hundred fifty-one treated patients. About one in five relapsed during treatment, and routine scans caught two thirds of those relapses, most already spread. Survival free of disease fell steadily over the first year. The figures give teams a realistic picture of what scheduled scanning finds, and when, during this treatment.
Catalog record
| CREATOR | Tamara J Huizer, Anniek Strijdhorst, Laurens V Beerepoot, Mark I van Berge Henegouwen, Leni van Doorn, Sarah Derks, Bas P L Wijnhoven, Bianca Mostert |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29450 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |